{"id":16102,"date":"2019-09-24T14:12:20","date_gmt":"2019-09-24T12:12:20","guid":{"rendered":"https:\/\/www.satt.fr\/satt-up-septembre-2019\/"},"modified":"2019-09-24T14:20:13","modified_gmt":"2019-09-24T12:20:13","slug":"satt-up-septembre-2019","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019"},"content":{"rendered":"
\n
\n
\n
\n

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Au programme : Lev\u00e9e de fonds, Lancements, r\u00e9compenses\u2026 Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 370 start-up Deep Tech #SATTUP !<\/strong><\/p>\n

 <\/p>\n

\"\"Erganeo participe \u00e0 la cr\u00e9ation de la start-up Ermium Therapeutics qui l\u00e8ve d\u00e9j\u00e0 6,3 millions d\u2019euros. <\/strong>(Erganeo)<\/em><\/p>\n

Ermium Therapeutics, est une soci\u00e9t\u00e9 de biotechnologie bas\u00e9e \u00e0 Paris qui d\u00e9veloppe des produits de sant\u00e9 innovants pour les maladies auto-immunes et inflammatoires. Laur\u00e9ate du Concours d\u2019Innovation i-Lab en juillet 2019, la start-up Ermium Therapeutics entame avec brio son ascension et confirme l\u2019int\u00e9r\u00eat que lui portent les investisseurs et industriels.\u00a0D\u00e8s 2016, Erganeo a soutenu le projet \u00e0 travers des d\u00e9p\u00f4ts de brevets ainsi qu\u2019un investissement total de 440 000 \u20ac.<\/p>\n

www.ermium.com<\/a><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n

\"\"Anagenesis Biotechnologies annonce la nomination du Professeur Gordon Keller \u00e0 son Conseil d\u2019Administration.<\/strong>\u00a0(Conectus)<\/em><\/p>\n

Anagenesis Biotechnologies (Anagenesis), annonce l\u2019entr\u00e9e du Professeur Gordon Keller dans son Conseil d’Administration. Le Professeur Keller est actuellement Directeur de l\u2019Institut des Cellules Souches McEwen, \u00e0 l\u2019Universit\u00e9 \u00ab Health Network \u00bb et Scientifique principal au Centre du Cancer Princess Margaret \u00e0 Toronto. Cofondateur scientifique de la soci\u00e9t\u00e9 de biotechnologie Bluerock Therapeutics, il apporte au Conseil d\u2019Administration d\u2019Anagenesis son expertise dans le domaine des cellules souches et de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative”.<\/p>\n

anagenesis-biotech.com<\/a><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n

\"\"La startup VAXXEL, soutenue par PULSALYS, d\u00e9veloppe un vaccin p\u00e9diatrique contre les pneumovirus.\u00a0<\/strong>(PULSALYS)<\/em><\/p>\n

R\u00e9compens\u00e9e lors du concours i-Lab 2019 pour son engagement dans la lutte contre les infections respiratoires \u00e0 pneumovirus, la startup VAXXEL, soutenue par PULSALYS et issue du Laboratoire de virologie VirPath rattach\u00e9 au Centre International de Recherche en Infectiologie (CIRI : INSERM, CNRS, UCBL, HCL, ENS), vise la mise au point d\u2019un nouveau vaccin p\u00e9diatrique intranasal. Alors qu\u2019aucun vaccin n\u2019est disponible sur le march\u00e9 contre ces pathologies, ce futur candidat vaccin bivalent ciblera \u00e0 la fois les pneumovirus hMPV (m\u00e9tapneumovirus humain, d\u00e9couvert r\u00e9cemment) et hRSV (virus respiratoire syncitial, VRS), tous deux en cause dans les bronchiolites et pneumonies, notamment chez les nourrissons.<\/p>\n

www.pulsalys.fr\/vaxxel<\/a><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n

\"\"La soci\u00e9t\u00e9 Pharm\u2019aging lance sa marque de cosmetique Artejia.<\/strong>\u00a0(SATT Nord)<\/em><\/p>\n

Nicolas EL ROBRINI, jeune docteur en biologie, lance une nouvelle gamme de cosm\u00e9tiques anti-\u00e2ge saine, efficace, scientifiquement prouv\u00e9e, respectueuse de la peau et de la plan\u00e8te : Artejia. La solution globale Artejia permet de pr\u00e9venir le vieillissement cutan\u00e9 du visage et r\u00e9volutionne la routine beaut\u00e9, avec uniquement 2 produits : Une cr\u00e8me de jour pr\u00e9ventive du vieillissement et hydratante – Un s\u00e9rum pr\u00e9ventif \u00e0 \u00ab effet bonne mine \u00bb \u00e0 utiliser pour le visage et le contour des yeux.<\/p>\n

www.pharmaging.com<\/a><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n

\"\"Dynacure Wins Ernst & Young\u2019s Prix \u201cBorn Global\u201d Award.<\/strong>\u00a0(Conectus)<\/em><\/p>\n

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that it has won the 2019 Ernst & Young\u2019s (EY) \u201cBorn Global\u201d award for \u2018Region Est\u2019, France. The award was received by Stephane van Rooijen (M.D. MBA), Chief Executive Officer of Dynacure, at the 2019 EY Entrepreneur of the Year awards ceremony on September 17.<\/p>\n

www.dynacure.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Au programme : Lev\u00e9e de fonds, Lancements, r\u00e9compenses\u2026 Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 370 start-up Deep Tech #SATTUP !   Erganeo participe \u00e0 la cr\u00e9ation de la start-up Ermium Therapeutics qui l\u00e8ve d\u00e9j\u00e0 6,3 millions d\u2019euros. (Erganeo) Ermium Therapeutics, […]<\/p>\n","protected":false},"author":2,"featured_media":11835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[562],"tags":[],"class_list":["post-16102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-satt-network"],"acf":[],"yoast_head":"\nSATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019\",\"datePublished\":\"2019-09-24T12:12:20+00:00\",\"dateModified\":\"2019-09-24T12:20:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/\"},\"wordCount\":546,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"articleSection\":[\"SATT Network\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"datePublished\":\"2019-09-24T12:12:20+00:00\",\"dateModified\":\"2019-09-24T12:20:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"width\":6399,\"height\":3569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-septembre-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019","datePublished":"2019-09-24T12:12:20+00:00","dateModified":"2019-09-24T12:20:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/"},"wordCount":546,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","articleSection":["SATT Network"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/","url":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/","name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","datePublished":"2019-09-24T12:12:20+00:00","dateModified":"2019-09-24T12:20:13+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","width":6399,"height":3569},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-septembre-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #10 \u2013 Septembre 2019"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/16102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=16102"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/16102\/revisions"}],"predecessor-version":[{"id":16103,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/16102\/revisions\/16103"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/11835"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=16102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=16102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=16102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}